Thymic carcinoma , Type B3 and Type B2 thymoma ranked the first higher expression rate of c-Jun; they were 87.5% (7/8), 45.5% (5/11), and 42.9% (6/14), respectively. The gene discussed is JUN; the disease is thymoma.